ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9623
-0.06%
Brent Oil
83.675
0.05%
Bitcoin
59,503.08
0.65%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cingulate Inc (CING)

  7. Cingulate Inc (CING) Noticias

CING Cingulate Inc

1.12
0.00 (0.00%)
Pre Mercado
Última actualización: 03:52:58
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cingulate Inc CING NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.12 03:52:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202404:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202416:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202407:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202415:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202405:45GLOBECingulate to Attend DCAT Week 2024 in New York City
26/2/202406:00EDGAR2Form 8-K - Current report
14/2/202416:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202405:50EDGAR2Form 8-K - Current report
13/2/202405:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
09/2/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202405:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202415:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
05/2/202416:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
04/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202408:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202416:01EDGAR2Form SC 13D/A - General statement of acquisition of..
29/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202407:59EDGAR2Form S-1/A - General form for registration of securities..
29/1/202407:05EDGAR2Form 8-K - Current report
29/1/202407:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202405:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
12/1/202416:03EDGAR2Form S-1 - General form for registration of securities under..
04/1/202416:15EDGAR2Form SC 13D/A - General statement of acquisition of..
02/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202305:02EDGAR2Form 8-K - Current report
15/12/202307:55EDGAR2Form 8-K - Current report
12/12/202316:00EDGAR2Form 8-K - Current report
06/12/202308:00EDGAR2Form RW - Registration Withdrawal Request
01/12/202308:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
28/11/202307:45EDGAR2Form 8-K - Current report
15/11/202308:00EDGAR2Form S-1 - General form for registration of securities under..
13/11/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
03/11/202315:15EDGAR2Form 8-K - Current report
19/10/202316:00EDGAR2Form 8-K - Current report
17/10/202313:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
02/10/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202307:06EDGAR2Form PRE 14A - Other preliminary proxy statements
21/9/202312:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
18/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
18/9/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/9/202315:15GLOBECingulate Announces Closing of $4.0 Million Public Offering

Su Consulta Reciente

NASDAQ
CING
Cingulate
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados